SLC22A12 Gene Hypouricemia Renal Type 1 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Renal Hypouricemia
The SLC22A12 Gene Hypouricemia Renal Type 1 NGS Genetic DNA Test represents a breakthrough in precision medicine for diagnosing hereditary renal disorders. This advanced genetic screening utilizes state-of-the-art Next-Generation Sequencing technology to identify specific mutations in the SLC22A12 gene, which plays a crucial role in uric acid transport within the kidneys. Understanding your genetic predisposition to renal hypouricemia enables healthcare providers to develop targeted treatment strategies and preventive measures.
What This Test Measures and Detects
Our comprehensive genetic analysis specifically targets the SLC22A12 gene, which encodes the URAT1 transporter protein responsible for uric acid reabsorption in the renal proximal tubules. The test identifies:
- Pathogenic variants and mutations in the SLC22A12 gene
- Single nucleotide polymorphisms affecting uric acid transport
- Deletions, insertions, and other structural variations
- Genetic markers associated with impaired renal urate handling
Who Should Consider This Genetic Test
This specialized genetic test is recommended for individuals experiencing:
- Unexplained persistently low serum uric acid levels
- Recurrent kidney stone formation despite normal uric acid levels
- Family history of renal hypouricemia or related kidney disorders
- Exercise-induced acute kidney injury episodes
- Uricosuric responses to standard medications
- Diagnostic uncertainty in cases of hypouricemia
Clinical Benefits of Genetic Testing
Undergoing the SLC22A12 genetic test provides numerous clinical advantages:
- Accurate Diagnosis: Confirms hereditary renal hypouricemia type 1 with precision
- Personalized Treatment: Enables tailored medication and lifestyle recommendations
- Family Planning: Provides genetic counseling information for family members
- Preventive Care: Helps implement strategies to prevent kidney complications
- Differential Diagnosis: Distinguishes between various causes of hypouricemia
Understanding Your Test Results
Our comprehensive genetic report provides detailed interpretation of your results:
- Positive Result: Indicates presence of pathogenic SLC22A12 mutations requiring specialized medical management
- Negative Result: Suggests alternative causes for hypouricemia symptoms
- Variant of Uncertain Significance: Requires additional clinical correlation and possible family testing
- Carrier Status: Important information for genetic counseling and family planning
Test Pricing Information
| Test Description | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent quality and reliable results nationwide.
Take Control of Your Genetic Health Today
Don’t let uncertainty about your renal health continue. Our SLC22A12 Gene Hypouricemia Renal Type 1 NGS Genetic DNA Test provides the clarity you need for informed medical decisions. With results delivered within 3-4 weeks and comprehensive genetic counseling support, you’ll gain valuable insights into your hereditary health risks.
Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic predisposition and optimizing your renal health management.
